ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,219Medicare Part D Prescriptions Filled, Including Refills

Rank: 374 out of 3647

$841K Total Retail Price of All Prescriptions

Rank: 363 out of 3647

623 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 623 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 623 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 10,894 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 693 537 1 1
OMEPRAZOLE 578 352 2 3
LEVOTHYROXINE SODIUM 558 400 3 5
LISINOPRIL 489 342 4 4
AMLODIPINE BESYLATE 480 394 5 2
METFORMIN HCL 467 347 6 6
LOVASTATIN 411 296 7 21
METOPROLOL TARTRATE 393 303 8 7
HYDROCHLOROTHIAZIDE 386 281 9 9
ZOLPIDEM TARTRATE 297 176 10 14
GABAPENTIN 292 180 11 17
POTASSIUM CHLORIDE 267 181 12 24
FUROSEMIDE 255 200 13 8
FLUTICASONE PROPIONATE 249 113 14 32
FENOFIBRATE 244 121 15 50
LOSARTAN POTASSIUM 238 181 16 11
CITALOPRAM HBR 220 151 17 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 206 153 18 36
GLIPIZIDE 202 137 19 41
WARFARIN SODIUM 184 130 20 15
HYDROCODONE-ACETAMINOPHEN 170 96 S3 21 12
TRAMADOL HCL 164 113 22 22
JANUVIA 153 99 23 72
ATORVASTATIN CALCIUM 140 104 24 13
CRESTOR 136 74 25 19
LABETALOL HCL 135 119 26 172
TRAZODONE HCL 132 78 27 64
ALENDRONATE SODIUM 132 112 27 23
LOSARTAN-HYDROCHLOROTHIAZIDE 128 112 29 48
CARVEDILOL 118 74 30 20
LIPITOR 117 76 31 113
LANTUS 109 71 32 59
AZITHROMYCIN 108 65 33 34
ALLOPURINOL 108 73 33 37
METOPROLOL SUCCINATE 106 70 35 18
ENALAPRIL MALEATE 106 67 35 35
GLIPIZIDE ER 105 86 37 112
CLONIDINE HCL 94 81 38 46
CLOPIDOGREL 94 70 38 26
PAROXETINE HCL 92 88 40 60
CYCLOBENZAPRINE HCL 91 18 R 41 98
PLAVIX 90 70 42 39
DONEPEZIL HCL 90 87 42 30
PRAVASTATIN SODIUM 89 69 44 16
PANTOPRAZOLE SODIUM 89 48 44 38
PROMETHAZINE HCL 88 24 R 46 182
ATENOLOL 88 76 46 10
ISOSORBIDE MONONITRATE ER 79 63 48 56
SPIRIVA 78 59 49 93
DIOVAN 78 67 49 40
OXYBUTYNIN CHLORIDE 76 50 51 107
DILTIAZEM HCL 74 53 52 253
DILTIAZEM 24HR CD 74 67 52 155
ADVAIR DISKUS 73 27 54 52
DOXAZOSIN MESYLATE 72 62 55 57
SPIRONOLACTONE 70 42 56 77
NAMENDA 70 70 56 49
LANTUS SOLOSTAR 69 46 58 124
DILTIAZEM ER 69 67 58 167
SERTRALINE HCL 68 23 60 27
LEVOFLOXACIN 67 41 61 87
EXELON 65 65 62 129
RISPERIDONE 64 43 63 83
DIOVAN HCT 64 63 63 80
TIZANIDINE HCL 63 40 65 126
FLUOXETINE HCL 62 12 66 68
TAMSULOSIN HCL 62 46 66 28
MECLIZINE HCL 61 56 68 85
DILTIAZEM 24HR ER 59 57 69 164
RANITIDINE HCL 57 35 70 29
GLYBURIDE 54 33 R 71 54
DIGOXIN 54 22 71 51
POLYETHYLENE GLYCOL 3350 54 38 71 143
GLIPIZIDE XL 53 52 74 190
KETOCONAZOLE 52 21 75 132
QUETIAPINE FUMARATE 52 37 75 89
ESCITALOPRAM OXALATE 52 35 75 65
NIFEDIPINE ER 51 44 78 67
PEN NEEDLE 51 25 78 166
SINGULAIR 50 26 80 90
TOPIRAMATE 50 0 80 254
SEROQUEL 50 38 80 185
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.